Victory Capital Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-20,024
| Closed | -$19.2K | – | 2600 |
|
|
2023
Q2 | $19.2K | Sell |
20,024
-466
| -2% | -$461 | ﹤0.01% | 2451 |
|
|
2023
Q1 | $15.4K | Buy |
20,490
+1,484
| +8% | +$1.08K | ﹤0.01% | 2525 |
|
|
2022
Q4 | $7K | Sell |
19,006
-7
| -0% | -$3 | ﹤0.01% | 2556 |
|
|
2022
Q3 | $8K | Sell |
19,013
-2,238
| -11% | -$2.2K | ﹤0.01% | 2670 |
|
|
2022
Q2 | $17K | Buy |
21,251
+2,783
| +15% | +$2.45K | ﹤0.01% | 2631 |
|
|
2022
Q1 | $15K | Sell |
18,468
-1,567
| -8% | -$1.44K | ﹤0.01% | 2654 |
|
|
2021
Q4 | $25K | Sell |
20,035
-638
| -3% | -$1.14K | ﹤0.01% | 2685 |
|
|
2021
Q3 | $45K | Sell |
20,673
-960
| -4% | -$2.62K | ﹤0.01% | 2693 |
|
|
2021
Q2 | $81K | Buy |
21,633
+1,956
| +10% | +$6.8K | ﹤0.01% | 2623 |
|
|
2021
Q1 | $64K | Sell |
19,677
-857
| -4% | -$3.07K | ﹤0.01% | 2647 |
|
|
2020
Q4 | $70K | Buy |
20,534
+147
| +0.7% | +$605 | ﹤0.01% | 2439 |
|
|
2020
Q3 | $83K | Buy |
20,387
+3,741
| +22% | +$14.2K | ﹤0.01% | 2354 |
|
|
2020
Q2 | $56K | Sell |
16,646
-14,436
| -46% | -$42.1K | ﹤0.01% | 2394 |
|
|
2020
Q1 | $72K | Buy |
31,082
+10,466
| +51% | +$28.6K | ﹤0.01% | 2639 |
|
|
2019
Q4 | $75K | Buy |
20,616
+5,294
| +35% | +$42.8K | ﹤0.01% | 2588 |
|
|
2019
Q3 | $127K | Buy |
+15,322
| New | +$124K | ﹤0.01% | 2367 |
|
Victory Capital Management's SPPI Position: Q3 2023 in Review
Victory Capital Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 20,024 shares — an estimated $19.2K sold.
Victory Capital Management first reported a position in SPPI in Q3 2019 and held it in 16 quarters. The position peaked at $127K in Q3 2019. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.
- Victory Capital Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
- Victory Capital Management sold 20,024 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $19.2K.
- Victory Capital Management first reported a position in Spectrum Pharmaceuticals Inc in Q3 2019 and held it in 16 quarters.
- Victory Capital Management's Spectrum Pharmaceuticals Inc position peaked at $127K in Q3 2019.
- 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.
Based on Victory Capital Management's 13F filing for Q3 2023, filed 6 Nov 2023.